We deliver specialized GMP-compliant facility design solutions tailored for modern veterinary vaccine manufacturing plants, covering inactivated vaccines, live attenuated vaccines, subunit vaccines and other mainstream animal biological products. All design specifications strictly comply with global veterinary biopharma GMP guidelines, ISO 14644 cleanroom standards and industry biosafety management codes. Adopting biosafety priority and process-driven design logic, we effectively address unique risks such as microbial leakage, biological cross-contamination and strain variability, constructing fully compliant, audit-ready production facilities for standardized veterinary vaccine research and commercial mass production.
Our professional design system focuses on core biosafety isolation and full-process contamination control for biological vaccine production. We implement scientific and closed functional zoning for seed cell preservation, virus culture, antigen preparation, purification, sterile formulation, filling and finished product storage. Strict physical isolation and dynamic airflow segregation are deployed between contaminated areas, polluted areas and clean areas, with customized positive and negative pressure gradient settings tailored for microbial operation zones. Hierarchical ISO 5 to ISO 8 clean classification, dedicated biosafety exhaust treatment systems and independent utility environments ensure zero cross-contamination and stable production environment safety throughout the process.
Covering full-lifecycle customized design services, our scope includes overall plant master planning, biosafety-level functional layout optimization, GMP cleanroom system design, specialized HVAC and purification system configuration, biosafety waste disposal system engineering, and complete MEP supporting system design. We optimize production line layout and personnel-material flow separation based on the unique characteristics of microbial fermentation and virus propagation processes. All structural and system designs meet high-standard sterilization, decontamination and daily maintenance requirements, supporting continuous, stable and safe GMP production operations.
Backed by in-depth veterinary biopharmaceutical engineering experience and standardized compliance systems, our design solutions balance biosafety, production efficiency and long-term scalability. Professional biosafety risk pre-control effectively avoids regulatory non-compliance issues and project rectification costs. Modular layout design and reserved expansion space adapt to future vaccine product iteration, process upgrading and capacity expansion. We help veterinary pharmaceutical enterprises build high-safety, efficient and certification-ready vaccine manufacturing bases, supporting standardized production registration and sustainable market development.
